Merck Sharp & Dohme (Australia)

PRIMAXIN

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  Primaxin;Cilastatin natrium;L 642957;MK 0791;MK 791;Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoate;UNII-5428WXZ74M;2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, monosodium salt, (R-(R*,S*-(Z)))-;Sodium hydrogen (R-(R*,S*-(Z)))-7-((2-amino-2-carboxylatoethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)hept-2-enoate;sodium (2Z)-7-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoate;sodium (2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoate;

• CAS NO :

  81129-83-1

• EC NO :

  279-694-4

• Molecular Formula :

  C₁₆H₂₅N₂NaO₅S

• Molecular Weight :

  380.4349

• Main Specifications :

• InChI :

  InChI=1/C16H26N2O5S.Na/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21;/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23);/q;+1/p-1/b12-6-;/t10-,11+;/m1./s1

• Molecular Structure :